Pharma-Deko Plc (PHARMD.ng) listed on the Nigerian Stock Exchange under the Pharmaceuticals sector has released it’s 2021 annual report.
For more information about Pharma-Deko Plc reports, abridged reports, interim earnings results and earnings presentations visit the Pharma-Deko Plc company page on AfricanFinancials.
Indicative Share Trading Liquidity
The total indicative share trading liquidity for Pharma-Deko Plc (PHARMD.ng) in the past 12 months, as of 4th March 2022, is US$59.31K (NGN70.34M). An average of US$4.94K (NGN5.86M) per month.
Pharma-Deko Plc Annual Report Document
Pharma-Deko Plc manufactures, packages and markets a range of pharmaceutical and consumer products in Nigeria. Pharmaceutical products include Parkalin cough syrup, Revitone blood tonic, Salins liniment, Hexdene mouth wash, Brett mouth wash, Omepraz, Pharmadec drops and syrups, Phardol suppository and drops, Amycin dry powder and capsules, Anuproct suppositories, Vitacee drops and syrups, Antasil tablets, garlic tablets, Amoquin anti-malarial tablets and Parkprim suspension and tablets. The company also produces and sells a non-sugar cream soda; and manufactures and packages pharmaceutical and consumer products under contract. Established in 1962 and formerly known as Parke-Davis & Company (US), the company changed its name to Pharma-Deko Limited in 1990. It is now known as Pharma-Deko Plc. The company head office is in Ogun State, Nigeria. Pharma-Deko Plc is listed on the Nigerian Stock Exchange